Isavuconazole: Difference between revisions
From IDWiki
No edit summary |
(→) |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
| + | == Background == |
||
| + | |||
| + | === Mechanism of Action === |
||
| + | |||
| + | * Azole antifungal that inhibits lanosterol 14-α demethylase in the peptidoglycan synthesis pathway |
||
| + | |||
| + | === Spectrum of Activity === |
||
| + | |||
| + | *Active against [[Candida]], [[Cryptococcus]], [[Aspergillus]] including [[Aspergillus flavus]], [[Aspergillus fumigatus]], and [[Aspergillus niger]], and [[Mucorales]] |
||
*Indications include {{#ask: [[Is treated by::isavuconazole]]}} |
*Indications include {{#ask: [[Is treated by::isavuconazole]]}} |
||
| Line 4: | Line 13: | ||
*Isavuconazole 200 mg IV tid for 6 doses followed by 200 mg IV daily |
*Isavuconazole 200 mg IV tid for 6 doses followed by 200 mg IV daily |
||
| + | |||
| + | === Renal Dosing === |
||
| + | |||
| + | * No adjustment needed |
||
| + | |||
| + | === Hepatic Dosing === |
||
| + | |||
| + | * No adjustment needed |
||
| + | |||
| + | == Safety == |
||
| + | |||
| + | === Adverse Drug Reactions === |
||
| + | |||
| + | * Nausea, vomiting, diarrhea |
||
| + | * Elevated liver enzymes |
||
| + | **Generally transient ALT elevation that does not require change in therapy |
||
| + | **May also include severe cholestatic or hepatocellular enzyme rises within the first few months of therapy |
||
| + | **See also [https://www.ncbi.nlm.nih.gov/books/NBK548643/ LiverTox] |
||
| + | * Hypokalemia |
||
| + | |||
| + | === Drug-Drug Interactions === |
||
| + | |||
| + | * Increases levels of [[sirolimus]] and [[tacrolimus]] |
||
| + | * Increases levels of [[cyclosporine]] |
||
| + | * Contraindicated with [[carbamazepine]] |
||
[[Category:Triazoles]] |
[[Category:Triazoles]] |
||
Latest revision as of 09:23, 30 March 2022
Background
Mechanism of Action
- Azole antifungal that inhibits lanosterol 14-α demethylase in the peptidoglycan synthesis pathway
Spectrum of Activity
- Active against Candida, Cryptococcus, Aspergillus including Aspergillus flavus, Aspergillus fumigatus, and Aspergillus niger, and Mucorales
- Indications include Chromoblastomycosis, Cladophialophora, Coccidioides immitis
Dosing
- Isavuconazole 200 mg IV tid for 6 doses followed by 200 mg IV daily
Renal Dosing
- No adjustment needed
Hepatic Dosing
- No adjustment needed
Safety
Adverse Drug Reactions
- Nausea, vomiting, diarrhea
- Elevated liver enzymes
- Generally transient ALT elevation that does not require change in therapy
- May also include severe cholestatic or hepatocellular enzyme rises within the first few months of therapy
- See also LiverTox
- Hypokalemia
Drug-Drug Interactions
- Increases levels of sirolimus and tacrolimus
- Increases levels of cyclosporine
- Contraindicated with carbamazepine
